HealthCare Global Enterprises Ltd (HCG) Q3FY26 Concall Summary - Dec-2025 Qtr
Performance Overview
- The company demonstrated resilient performance in a seasonally soft quarter, achieving a revenue of INR 633 crores, marking a 13.4% year-on-year growth, driven by an 8% increase in patient volumes.
- Profitability saw significant improvement, with adjusted EBITDA growing 20% year-on-year to INR 111 crores, leading to an EBITDA margin expansion of 100 basis points to 17.5%.
- The company's digital engine proved to be a key growth driver, with digital revenue increasing by 26% year-on-year, supported by a 4.5x scaling of the mobile app's contribution and improved campaign efficiency.
- Performance across regional clusters remained healthy, with the West cluster showing strong 17% YoY revenue growth, while the South and East clusters grew by 9% and 12% respectively, despite some temporary disruptions.
- The company is advancing its growth strategy through brownfield expansions in high-potential markets like Cuttack and Bangalore, alongside progressing well on its greenfield projects in North Bangalore and Whitefield.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.